00906nas a2200385   4500000000100000008004100001260001300042653002700055653001500082653001000097653002300107653001600130653002500146653001000171653002100181653002400202653001100226653001100237653001000248653001100258653002000269653001200289653001100301653000900312653001600321653002500337653002200362653001400384100001400398245003600412856004100448300001000489490000700499022001400506       1998                            d  c1998 Dec10aAdjuvants, Immunologic10aAdolescent10aAdult10aBacterial Vaccines10aBCG Vaccine10aCase-Control Studies10aChild10aChild, Preschool10aDouble-Blind Method10aFemale10aHumans10aIndia10aInfant10aInfant, Newborn10aleprosy10aMalawi10aMale10aMiddle Aged10aMycobacterium leprae10aRandom Allocation10aVenezuela1 aGupte M D00aVaccine trials against leprosy.  uhttp://ila.ilsl.br/pdfs/v66n4a36.pdf  a587-90 v66  a0148-916X